Purighalla Swathi, Esakimuthu Sarita, Reddy Mallika, Varghese George K, Richard Vijay S, Sambandamurthy Vasan K
Department of Hospital Infection Control, Narayana Health City, Bengaluru, Karnataka, India.
Department of Microbiology, Narayana Health City, Bengaluru, Karnataka, India.
Indian J Med Microbiol. 2017 Jul-Sep;35(3):361-368. doi: 10.4103/ijmm.IJMM_16_308.
The purpose of this study was to evaluate the discriminatory power of two DNA-based technique and a protein-based technique for the typing of nosocomial isolates of Klebsiella pneumoniae. A second objective was to determine the antimicrobial susceptibility pattern and characterise the presence of genes encoding extended-spectrum beta-lactamases (ESBLs) and carbapenemases.
Forty-six K. pneumoniae isolates from patients with bloodstream infections at a tertiary care hospital in India between December 2014 and December 2015 were studied. All isolates were typed using enterobacterial repetitive intergenic consensus sequence-polymerase chain reaction (ERIC-PCR), randomly amplified polymorphic DNA (RAPD) analysis and matrix-assisted laser desorption ionisation time-of-flight (MALDI-TOF) mass spectrometry. Antimicrobial susceptibility profiles and ESBLs were detected using the BD Phoenix system. The types of ESBL and carbapenemase genes present were detected using PCR.
Isolates were subtyped into 31, 30 and 33 distinct genotypes by ERIC-PCR, RAPD and MALDI-TOF, respectively. Several isolates displaying identical DNA fingerprints were binned into different branches based on their proteomic fingerprint. Antimicrobial susceptibility tests revealed that 33/46 strains were multidrug resistant (MDR); a majority of the strains (83%) were sensitive to colistin. PCR-based analysis demonstrated 19 strains to harbour two or more ESBL and carbapenemase genes.
ERIC-PCR was the most reproducible method for typing K. pneumoniae isolates and could not be substituted by MALDI-TOF for clonality analysis. A high degree of genetic diversity and the presence of MDR genes highlight the challenges in treating K. pneumoniae-associated infections.
本研究旨在评估两种基于DNA的技术和一种基于蛋白质的技术对医院内分离的肺炎克雷伯菌进行分型的鉴别能力。第二个目的是确定抗菌药物敏感性模式,并鉴定编码超广谱β-内酰胺酶(ESBLs)和碳青霉烯酶的基因的存在情况。
对2014年12月至2015年12月期间印度一家三级护理医院的46株血流感染患者的肺炎克雷伯菌分离株进行了研究。所有分离株均采用肠杆菌重复基因间共识序列-聚合酶链反应(ERIC-PCR)、随机扩增多态性DNA(RAPD)分析和基质辅助激光解吸电离飞行时间(MALDI-TOF)质谱法进行分型。使用BD Phoenix系统检测抗菌药物敏感性谱和ESBLs。使用PCR检测存在的ESBL和碳青霉烯酶基因类型。
ERIC-PCR、RAPD和MALDI-TOF分别将分离株分为31、30和33个不同的基因型。一些显示相同DNA指纹的分离株根据其蛋白质组指纹被归为不同的分支。抗菌药物敏感性测试显示,33/46株为多重耐药(MDR);大多数菌株(83%)对黏菌素敏感。基于PCR的分析表明,19株菌株携带两种或更多种ESBL和碳青霉烯酶基因。
ERIC-PCR是对肺炎克雷伯菌分离株进行分型的最可重复的方法,在克隆性分析中不能被MALDI-TOF替代。高度的遗传多样性和MDR基因的存在突出了治疗肺炎克雷伯菌相关感染的挑战。